1. Home
  2. TROO vs TARA Comparison

TROO vs TARA Comparison

Compare TROO & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TROOPS Inc.

TROO

TROOPS Inc.

HOLD

Current Price

$2.09

Market Cap

287.1M

Sector

Technology

ML Signal

HOLD

Logo Protara Therapeutics Inc.

TARA

Protara Therapeutics Inc.

HOLD

Current Price

$4.08

Market Cap

236.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TROO
TARA
Founded
2005
N/A
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
287.1M
236.1M
IPO Year
2008
2014

Fundamental Metrics

Financial Performance
Metric
TROO
TARA
Price
$2.09
$4.08
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$24.40
AVG Volume (30 Days)
475.6K
771.6K
Earning Date
05-01-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
38.25
EPS
N/A
N/A
Revenue
N/A
$2,948,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.67
$2.97
52 Week High
$5.28
$7.82

Technical Indicators

Market Signals
Indicator
TROO
TARA
Relative Strength Index (RSI) 40.82 46.93
Support Level $1.52 $3.69
Resistance Level $2.89 $4.23
Average True Range (ATR) 0.36 0.20
MACD 0.03 0.02
Stochastic Oscillator 61.08 35.71

Price Performance

Historical Comparison
TROO
TARA

About TROO TROOPS Inc.

TROOPS Inc is a conglomerate group of various businesses with its headquarters based in Hong Kong. The group is principally engaged in money lending business in Hong Kong providing mortgage loans to high quality target borrowers, property investment to generate additional rental income and the development, operation and management of an online financial marketplace that provides one-stop financial technology solutions including API services by leveraging artificial intelligence, large data and blockchain, and cloud computing (SaaS). It derives revenue from Hong Kong and Australia. Majority of its revenue generates from domestic market.

About TARA Protara Therapeutics Inc.

Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.

Share on Social Networks: